SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Taiho Pharmaceutical: Teysuno(TM) (S-1) Receives CHMP Positive Opinion for Approval as First-Line Therapy for Advanced Gastric Cancer